Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Margarita Majem's publication output changed over time?
ScholarIQpublication output · 2009–2015
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2015.
1
1
20092015
What are the most-cited papers on Margarita Majem?
ScholarIQmost cited works
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
The Lancet. 20156,550 Citations
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rafael Rosell, Teresa Morán, Cristina Queralt, Rut Porta, Felipe Cardenal, Carlos Camps, Margarita Majem, Guillermo López-Vivanco, Dolores Isla, Mariano Provencio, Amelia Insa, Bartomeu Massutí, J.L. González-Larriba, Luis Paz‐Ares, Isabel Bover, Rosario García‐Campelo, Miguel Ángel Moreno, Sílvia Catot, Christian Rolfo, Noemı́ Reguart, Ramón Palmero, José Miguel Sánchez, Roman Bastus, Clara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina‐Vila, José Javier Sánchez, Miquel Tarón
New England Journal of Medicine. 20092,381 CitationsOPEN ACCESS
Related on ScholarIQ
Hospital de Sant Pau
University
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Paper
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Paper
Cancer Immunotherapy and Biomarkers
Topic
Cancer Genomics and Diagnostics
Topic
Lung Cancer Treatments and Mutations
Topic